Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6
Gespeichert in:
Veröffentlicht in: | Clinical cancer research 2015-09, Vol.22 (2), p.405-414 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 414 |
---|---|
container_issue | 2 |
container_start_page | 405 |
container_title | Clinical cancer research |
container_volume | 22 |
creator | Ziemke, Elizabeth K. Dosch, Joseph S. Maust, Joel D. Shettigar, Amrith Sen, Ananda Welling, Theodore H. Hardiman, Karin M. Sebolt-Leopold, Judith S. |
description | |
doi_str_mv | 10.1158/1078-0432.CCR-15-0829 |
format | Article |
fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4715945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4715945</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_47159453</originalsourceid><addsrcrecordid>eNqljMtqwzAQRbVoadLHJxTmB5RItuzYm0JRUwImm8R7M3GUWMWWjDQJ-O_bQil03dWBcy6XsWcpFlJmxVKKVcGFSpOF1jsuMy6KpLxh818_Y_cxfgghlRTqjs2SPM3LPJVz1u6Ni5bs1dIE_gTV7nXPtxdCR6B974NpCXvQ6FoTIpD_ssPBOiTrHdSdCThOQB1-z3mN4WwownZdAboj6LdKLfNHdnvCPpqnHz6wl_d1rTd8vBwGc2yNo4B9MwY7YJgaj7b5W5ztmrO_Nmols1Jl6b8PPgH5PGJP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><source>Alma/SFX Local Collection</source><creator>Ziemke, Elizabeth K. ; Dosch, Joseph S. ; Maust, Joel D. ; Shettigar, Amrith ; Sen, Ananda ; Welling, Theodore H. ; Hardiman, Karin M. ; Sebolt-Leopold, Judith S.</creator><creatorcontrib>Ziemke, Elizabeth K. ; Dosch, Joseph S. ; Maust, Joel D. ; Shettigar, Amrith ; Sen, Ananda ; Welling, Theodore H. ; Hardiman, Karin M. ; Sebolt-Leopold, Judith S.</creatorcontrib><identifier>ISSN: 1078-0432</identifier><identifier>DOI: 10.1158/1078-0432.CCR-15-0829</identifier><identifier>PMID: 26369631</identifier><language>eng</language><ispartof>Clinical cancer research, 2015-09, Vol.22 (2), p.405-414</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,27929,27930</link.rule.ids></links><search><creatorcontrib>Ziemke, Elizabeth K.</creatorcontrib><creatorcontrib>Dosch, Joseph S.</creatorcontrib><creatorcontrib>Maust, Joel D.</creatorcontrib><creatorcontrib>Shettigar, Amrith</creatorcontrib><creatorcontrib>Sen, Ananda</creatorcontrib><creatorcontrib>Welling, Theodore H.</creatorcontrib><creatorcontrib>Hardiman, Karin M.</creatorcontrib><creatorcontrib>Sebolt-Leopold, Judith S.</creatorcontrib><title>Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6</title><title>Clinical cancer research</title><issn>1078-0432</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqljMtqwzAQRbVoadLHJxTmB5RItuzYm0JRUwImm8R7M3GUWMWWjDQJ-O_bQil03dWBcy6XsWcpFlJmxVKKVcGFSpOF1jsuMy6KpLxh818_Y_cxfgghlRTqjs2SPM3LPJVz1u6Ni5bs1dIE_gTV7nXPtxdCR6B974NpCXvQ6FoTIpD_ssPBOiTrHdSdCThOQB1-z3mN4WwownZdAboj6LdKLfNHdnvCPpqnHz6wl_d1rTd8vBwGc2yNo4B9MwY7YJgaj7b5W5ztmrO_Nmols1Jl6b8PPgH5PGJP</recordid><startdate>20150914</startdate><enddate>20150914</enddate><creator>Ziemke, Elizabeth K.</creator><creator>Dosch, Joseph S.</creator><creator>Maust, Joel D.</creator><creator>Shettigar, Amrith</creator><creator>Sen, Ananda</creator><creator>Welling, Theodore H.</creator><creator>Hardiman, Karin M.</creator><creator>Sebolt-Leopold, Judith S.</creator><scope>5PM</scope></search><sort><creationdate>20150914</creationdate><title>Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6</title><author>Ziemke, Elizabeth K. ; Dosch, Joseph S. ; Maust, Joel D. ; Shettigar, Amrith ; Sen, Ananda ; Welling, Theodore H. ; Hardiman, Karin M. ; Sebolt-Leopold, Judith S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_47159453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ziemke, Elizabeth K.</creatorcontrib><creatorcontrib>Dosch, Joseph S.</creatorcontrib><creatorcontrib>Maust, Joel D.</creatorcontrib><creatorcontrib>Shettigar, Amrith</creatorcontrib><creatorcontrib>Sen, Ananda</creatorcontrib><creatorcontrib>Welling, Theodore H.</creatorcontrib><creatorcontrib>Hardiman, Karin M.</creatorcontrib><creatorcontrib>Sebolt-Leopold, Judith S.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ziemke, Elizabeth K.</au><au>Dosch, Joseph S.</au><au>Maust, Joel D.</au><au>Shettigar, Amrith</au><au>Sen, Ananda</au><au>Welling, Theodore H.</au><au>Hardiman, Karin M.</au><au>Sebolt-Leopold, Judith S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6</atitle><jtitle>Clinical cancer research</jtitle><date>2015-09-14</date><risdate>2015</risdate><volume>22</volume><issue>2</issue><spage>405</spage><epage>414</epage><pages>405-414</pages><issn>1078-0432</issn><pmid>26369631</pmid><doi>10.1158/1078-0432.CCR-15-0829</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-0432 |
ispartof | Clinical cancer research, 2015-09, Vol.22 (2), p.405-414 |
issn | 1078-0432 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4715945 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research; Alma/SFX Local Collection |
title | Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T07%3A41%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sensitivity%20of%20KRAS-Mutant%20Colorectal%20Cancers%20to%20Combination%20Therapy%20that%20Co-Targets%20MEK%20and%20CDK4/6&rft.jtitle=Clinical%20cancer%20research&rft.au=Ziemke,%20Elizabeth%20K.&rft.date=2015-09-14&rft.volume=22&rft.issue=2&rft.spage=405&rft.epage=414&rft.pages=405-414&rft.issn=1078-0432&rft_id=info:doi/10.1158/1078-0432.CCR-15-0829&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4715945%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26369631&rfr_iscdi=true |